ACER, E. Et Al. 2019. The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria. CUTANEOUS AND OCULAR TOXICOLOGY , vol.38, no.1 , 5-8.

ACER, E., KAYA ERDOĞAN, H., Canakci, N. Y., & SARAÇOĞLU, Z. N., (2019). The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria. CUTANEOUS AND OCULAR TOXICOLOGY , vol.38, no.1, 5-8.

ACER, ERSOY Et Al. "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria," CUTANEOUS AND OCULAR TOXICOLOGY , vol.38, no.1, 5-8, 2019

ACER, ERSOY Et Al. "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria." CUTANEOUS AND OCULAR TOXICOLOGY , vol.38, no.1, pp.5-8, 2019

ACER, E. Et Al. (2019) . "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria." CUTANEOUS AND OCULAR TOXICOLOGY , vol.38, no.1, pp.5-8.

@article{article, author={ERSOY ACER Et Al. }, title={The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria}, journal={CUTANEOUS AND OCULAR TOXICOLOGY}, year=2019, pages={5-8} }